A study investigating the predictive power of Gal-3 for post-stroke cognitive impairment found that serum Gal-3 levels were significantly higher in the patient group and that higher levels were proportional to the likelihood of developing post-stroke cognitive impairment [34]. This evidence concerns the gene LGALS3 and Stroke.